Search - tctmd.com

Displaying 901 - 920 of 2380

Sort: Relevancy | Date

Before Age 35, Women More Vulnerable to Ischemic Stroke Than Men

News Daily News

Before Age 35, Women More Vulnerable to Ischemic Stroke Than Men

January 26, 2022

COVID-19: TCTMD’s Dispatch for January Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 4

January 24, 2022

Featured Fellow: Navjot Kaur Sobti, MD

News Featured Fellow

Navjot Kaur Sobti, MD

Yael L. Maxwell

January 21, 2022

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

News Daily News

Cardiac Abnormalities Seen After COVID-19, but Recovery Is Quick

Michael O'Riordan

January 20, 2022

Yet Another US Report Shows Stalled Progress Against CHD

News Daily News

Yet Another US Report Shows Stalled Progress Against CHD

January 19, 2022

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

January 14, 2022

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

January 07, 2022

Myocardial Injury Tied to Greater Mortality 1 Year After COVID-19 Hospitalization

News Daily News

Myocardial Injury Tied to Greater Mortality 1 Year After COVID-19 Hospitalization

January 06, 2022

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

News Daily News

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

Yael L. Maxwell

January 03, 2022

January 2022 News Roundup

News Opinion CV Team Dispatch

January 2022 News Roundup

January 01, 2022

Progress Against Acute MI Deaths in Nonelderly US Adults Has Plateaued

News Daily News

Progress Against Acute MI Deaths in Nonelderly US Adults Has Plateaued

December 30, 2021

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

News Daily News

MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission

December 29, 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

News Daily News

Still No Edge for Bivalirudin in VALIDATE-SWEDEHEART’s STEMI Patients

December 22, 2021

Women Less Likely Than Men to Experience SCD During Sports

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

Studies Zero in on Delayed Conduction Problems After TAVI

News Daily News

Studies Zero in on Delayed Conduction Problems After TAVI

December 21, 2021

For Angina Patients, Language Barriers Can Complicate CVD Care

News Daily News

For Angina Patients, Language Barriers Can Complicate CVD Care

December 20, 2021

Negar Salehi, MD

News Featured Fellow

Negar Salehi, MD

Yael L. Maxwell

December 16, 2021

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

News Daily News

Adapted D-Dimer Thresholds Safe, Efficient for Acute PE Diagnosis

December 16, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.